ArticleFrontiers in oncology2025

Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression.

Sei Morinaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.